A serious but often missed sign is confusion or trouble thinking clearly. This is called hepatic encephalopathy. It happens when the liver can’t remove toxins from the blood, and those toxins reach ...
Korro Bio (NASDAQ:KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing therapeutic candidate the company believes could provide a new approach to ...
Explore the critical connection between alcohol consumption, liver cirrhosis, and the urgent need for early intervention and ...
aInstitute of Liver Studies, King's College Hospital National Health Services Foundation Trust, London, UK bFetal Medicine Research Unit, King's College Hospital National Health Services Foundation ...
Shares of Bausch Health BHC were down 1.86% on Jan. 26. This was the second consecutive session when shares slid. BHC stock ...
LITTLE Beckett Wear was forced to relearn how to walk and talk after a bout of the flu caused a catastrophic brain disorder.
Bausch Health’s RED-C phase 3 clinical programme of amorphous-rifaximin SSD in adults with liver cirrhosis for primary prevention of HE fails to meet primary endpoint: Laval, Ca ...
Rifaximin SSD failed to significantly delay the onset of HE in patients with liver cirrhosis, but Bausch is yet to scrap the ...
A hole has been blown in Bausch Health's late-stage pipeline, after a follow-up to its top-selling drug product Xifaxan ...
Bausch Health said on Friday its experimental treatment failed to prevent the first clinically visible symptoms of a neurological condition in patients with a type of liver disease, missing the main ...
After contracting the flu, four-year-old Beckett Ware developed a rare and deadly brain inflammation called acute necrotizing ...
Bausch Health Companies Inc. was hit by a failed RED-C Phase 3, weak cash flow vs. interest, and a risky pipeline. Click for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results